Free Trial

Addus HomeCare (NASDAQ:ADUS) Announces Earnings Results

Addus HomeCare logo with Medical background

Addus HomeCare (NASDAQ:ADUS - Get Free Report) released its quarterly earnings results on Monday. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09, Briefing.com reports. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same quarter last year, the business posted $1.21 earnings per share. Addus HomeCare's revenue was up 20.3% compared to the same quarter last year.

Addus HomeCare Trading Up 0.5 %

Addus HomeCare stock traded up $0.55 on Friday, hitting $111.25. 21,540 shares of the stock traded hands, compared to its average volume of 212,313. The business's fifty day simple moving average is $98.52 and its 200 day simple moving average is $114.60. The firm has a market cap of $2.05 billion, a P/E ratio of 25.46, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. Addus HomeCare has a 1 year low of $88.96 and a 1 year high of $136.72.

Analyst Ratings Changes

Several research firms recently commented on ADUS. Oppenheimer boosted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Macquarie lifted their target price on shares of Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research report on Thursday. Stephens restated an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, JMP Securities restated a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $142.57.

View Our Latest Analysis on ADUS

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Earnings History for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines